The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Patient-reported outcomes in metastatic breast cancer: QoL, needs, and expectations of survivors.
 
Maira Caleffi
No Relationships to Disclose
 
Norah Ana Burchardt
No Relationships to Disclose
 
Helio Pasqualotto Scapin
No Relationships to Disclose
 
Isabel Crivelatti
No Relationships to Disclose
 
Carlos Spode Gomes
No Relationships to Disclose
 
Ana Lucia Gomes
No Relationships to Disclose
 
Paula Raffin Pohlmann
Leadership - Immunonet BioSciences
Stock and Other Ownership Interests - Immunonet BioSciences
Consulting or Advisory Role - Immunonet BioSciences; OncoPlex Diagnostics; Personalized Cancer Therapy
Patents, Royalties, Other Intellectual Property - IMMUNOLOGICAL COMPOSITIONS AS CANCER BIOMARKERS AND/OR THERAPEUTICS; U.S. Patent and Trademark Office No. US 20120201820. Invention title: Immunological Compositions as Cancer Therapeutics.